Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Biologics Drug Discovery Market 2017-2025 - Focus on Method/Phase, Product Type, Manufacturer Type and Competitive Landscape - Research and Markets

Research and Markets
Posted on: 09 Aug 17

The "Global Biologics Drug Discovery Market Analysis and Forecast, 2017-2025: Focus on Method/Phase, Product Type, Manufacturer Type and Competitive Landscape" report has been added to Research and Markets' offering.

Global Biologics Drug Discovery Market to Reach $22 Billion by 2025

Geographically, biologics have registered near double digit annual growth rate, whereas, the pharmaceutical drugs registered only single digit annual growth rate, in the past five years.

This double digit growth was largely fuelled by the substantial investments of the major pharmaceutical companies, who realized the potential of the market quite early. Biologics are defined as pharmaceutical products obtained from living cells or micro-organisms. These are complex & large molecules consisting of proteins, peptides, nucleic acids, sugars, cellular structures or a combination of these.

The biologics drug discovery involves target identification, hit-to-lead stage, lead identification & optimization. Technologies used for the development of biologics include genomics, proteomics, microarrays, cell cultures, phage display technologies and monoclonal antibody technologies among others. The market analysis includes an in-depth examination of the key ecosystem players and key strategies & developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities and challenges) and industry analysis.

Key Topics Covered:

1 Report Scope

2 Market Overview

3 Industry Insights

  • Regulatory Scenario
  • Patent Landscape

4 Competitive Landscape

5 Global Biologics Drug Discovery Market, by Product

  • Small Molecule Vs. Biologicals
  • Biologicals
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Other biologics

6 Global Biologics Drug Discovery Market, by Phase

  • Target Identification/Validation
  • Functional Genomics/Proteomics
  • Computational Approach/In-silico
  • Cell based Assay
  • Knock out studies/CRISPR/Cas9
  • Animal/Disease Based Models
  • Hit Generation
  • Lead Identification
  • Lead Optimization

7 Global Biologics Drug Discovery Market, by Manufacture Type

  • Type of Manufacturing
  • In-House Manufacturing
  • Advantages of Outsourcing Development
  • Outsourced Manufacturing

8 Global Biologics Drug Discovery Market, by Geography

9 Company Profiles

  • Abbvie Inc
  • Albany Molecular Research Inc
  • Allergan Plc
  • Amgen Inc
  • Aptuit
  • Astellas Pharma Inc
  • Astrazeneca Plc
  • Atellas Pharma Inc
  • Bayer Ag
  • Biocon Ltd
  • Boehringer Ingelheim Gmbh
  • Bristol-Myers Squibb Company
  • Charles River Laboratories International, Inc
  • Eli Lilly And Company
  • Evotec Ag
  • F Hoffmann-La Roche Ag
  • Genscript
  • Gilead Sciences Inc
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • Laboratory Corporation Of America Holdings
  • Merck & Co, Inc
  • Merck Kgaa
  • Novartis Ag
  • Novo Nordisk
  • Pfizer Inc
  • Sanofi
  • Teva Pharmaceuticals
  • Wuxi Apptec

For more information about this report visit

View source version on

Business Wire

Last updated on: 09/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.